A Fully Integrated Assay Panel for Early Drug Metabolism and Pharmacokinetics Profiling-Reference-Cited by-同舟云学术

A Fully Integrated Assay Panel for Early Drug Metabolism and Pharmacokinetics Profiling

Published:2020-05-01 Issue:4 Volume:18 Page:157-179
ISSN:1540-658X
Container-title:ASSAY and Drug Development Technologies
language:en
Short-container-title:ASSAY and Drug Development Technologies

Author:

Wernevik Johan¹,Bergström Fredrik²,Novén Anna¹,Hulthe Johan¹,Fredlund Linda¹,Addison Dan³,Holmgren Jan⁴,Strömstedt Per-Erik¹,Rehnström Erika⁵,Lundbäck Thomas¹

Affiliation:

1. Mechanistic Biology & Profiling, Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden.

2. DMPK, Early CVRM, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.

3. Sample Management, Discovery Sciences, R&D, AstraZeneca, Cambridge, United Kingdom.

4. Sample Management, Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden.

5. Clinical Sampling & Alliances, Precision Medicine, AstraZeneca, Gothenburg, Sweden.

Publisher

Mary Ann Liebert Inc

Subject

Drug Discovery,Molecular Medicine

Link

https://www.liebertpub.com/doi/pdf/10.1089/adt.2020.970

Reference57 articles.

1. Impact of a five-dimensional framework on R&D productivity at AstraZeneca

2. High throughput physicochemical profiling for drug discovery

3. Focus on success: using a probabilistic approach to achieve an optimal balance of compound properties in drug discovery

4. The right compound in the right assay at the right time: an integrated discovery DMPK strategy

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incorporation of an Isohexide Subunit into the Endochin-like Quinolone Scaffold;Molecules;2024-07-31

2. High-throughput kinetics in drug discovery;SLAS Discovery;2024-07

3. Design of a Lead-Like Cysteine-Targeting Covalent Library and the Identification of Hits to Cys55 of Bfl-1;Journal of Medicinal Chemistry;2024-06-25

4. Augmenting DMTA using predictive AI modelling at AstraZeneca;Drug Discovery Today;2024-04

5. Optimization of Potent Ligands for the E3 Ligase DCAF15 and Evaluation of Their Use in Heterobifunctional Degraders;Journal of Medicinal Chemistry;2024-03-21